Identification of Yju3p as functional orthologue of mammalian monoglyceride lipase in the yeast Saccharomyces cerevisiae  by Heier, Christoph et al.
Biochimica et Biophysica Acta 1801 (2010) 1063–1071
Contents lists available at ScienceDirect
Biochimica et Biophysica Acta
j ourna l homepage: www.e lsev ie r.com/ locate /bba l ipIdentiﬁcation of Yju3p as functional orthologue of mammalian monoglyceride lipase
in the yeast Saccharomyces cerevisiae
Christoph Heier 1, Ulrike Taschler 1, Srinivasan Rengachari, Monika Oberer, Heimo Wolinski, Klaus Natter,
Sepp D. Kohlwein, Regina Leber ⁎,2, Robert Zimmermann
Institute of Molecular Biosciences, University of Graz, Humboldtstrasse 50, A-8010 Graz, AustriaAbbreviations: MAG, monoacylglycerol; MGL, mo
monoacylglycerol hydrolase; MGAT, acyl-CoA:mono
DGAT, acyl-CoA:diacylglycerol acyltransferase; EC, endo
chidonoyl glycerol; LD, lipid droplet; TAG, triacylglyce
diacylglycerol; GFP, green ﬂuorescent protein; NAPE
mine; NAE, N-acylethanolamide; AEA, N-arachidonoyl e
⁎ Corresponding author. Applied Biocatalysis Resear
8010 Graz, Austria. Tel.: +43 316 873 9342; fax: +43 3
E-mail address: regina.leber@a-b.at (R. Leber).
1 These authors contributed equally to this work.
2 Present address: Applied Biocatalysis Research Cente
Austria.
1388-1981 © 2010 Elsevier B.V.
doi:10.1016/j.bbalip.2010.06.001
Open access under CC BYa b s t r a c ta r t i c l e i n f oArticle history:
Received 22 January 2010
Received in revised form 19 May 2010
Accepted 1 June 2010
Available online 8 June 2010
Keywords:
Monoacylglycerols
Monoglyceride lipase
MGAT activity
YeastMonoacylglycerols (MAGs) are short-lived intermediates of glycerolipidmetabolism. Speciﬁc molecular species,
such as 2-arachidonoylglycerol, which is a potent activator of cannabinoid receptors, may also function as lipid
signalingmolecules. Inmammals, enzymes hydrolyzingMAG to glycerol and fatty acids, resembling theﬁnal step
in lipolysis, or esterifyingMAG to diacylglycerol, are well known; however, despite the high level of conservation
of lipolysis, the corresponding activities in yeast have not been characterized yet. Here we provide evidence that
the proteinYju3p functions as a potentMAGhydrolase inyeast. CellularMAGhydrolase activitywasdecreasedby
more than 90% in extracts of Yju3p-deﬁcient cells, indicating that Yju3p accounts for the vast majority of this
activity in yeast. Loss of this activity was restored by heterologous expression of murine monoglyceride lipase
(MGL). Since yju3Δ mutants accumulated MAG in vivo only at very low concentrations, we considered the
possibility that MAGs are re-esteriﬁed into DAG by acyltransferases. Indeed, cellular MAG levels were further
increased in mutant cells lacking Yju3p and Dga1p or Lro1p acyltransferase activities. In conclusion, our studies
suggest that catabolic and anabolic reactions affect cellular MAG levels. Yju3p is the functional orthologue of
mammalian MGL and is required for efﬁcient degradation of MAG in yeast.noacylglycerol lipase; MGH,
acylglycerol acyltransferase;
cannabinoid; 2-AG, 2-aracha-
rol; FFA, free fatty acid; DAG,
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Monoacylglycerols (MAGs) are important intermediates in mam-
malian lipid metabolism. In the intestine, 2-MAG results from
triacylglycerol (TAG) hydrolysis that is catalyzed by pancreatic lipase.
MAG and free fatty acids (FFAs) are taken up by enterocytes and are re-
esteriﬁed by monoacylglycerol acyltransferases (MGATs) to diacylgly-
cerol (DAG) [1]. This process is essential for the efﬁcient packaging of
dietary fat into chylomicron lipoprotein particles [2]. In the circulation,
TAG-rich lipoproteins are hydrolyzed by lipoprotein lipase (LPL),
generating MAG and FFA [3]. These lipolytic products are internalized
by tissues and further processed for lipid synthesis or energyconversion.
Within cells, MAG may derive from the catabolism of TAG, which iscatalyzed by the combined action of adipose triglyceride lipase (ATGL)
and hormone-sensitive lipase (HSL) [4], or from glycerophospholipid
degradation. In mammals, monoacylglycerol lipase (MGL or MAGL) is
suggested to carry out the rate-limiting step of MAG hydrolysis. MGL
activities have been detected in rat tissues already in the seventies, and
the respective enzymes have also been subjected to puriﬁcation [5].
MGL is a member of the serine hydrolase family and ubiquitously
expressed [6]. The enzyme has a high substrate speciﬁcity for MAG, but
low stereoselectivity. MammalianMGL catalyzes the hydrolysis of rac-1
(3)- and 2-MAG at equal rates, and has no activity against trioleoylgly-
cerol, dioleoylglycerol, cholesteryl oleate, or lysophosphatidylcholine
in vitro [5].
SpeciﬁcMAG species, however, are not only intermediary products
of lipid metabolism but also possess signaling function. In mammals,
2-arachidonoylglycerol (2-AG) belongs to the family of endocanna-
binoids (EC), which are endogenous agonists of cannabinoid receptors
[7]. ECs are involved in the control of many biological processes
including behavior, appetite regulation, pain, blood pressure, energy
metabolism, inﬂammation, and cell growth. Their biological effect is
mimicked by Δ9-tetrahydrocannabinol (THC), the major psychoactive
component of marijuana. The broad spectrum of bioactivities of EC
compounds has attracted great interest in pharmacological research;
however, their clinical use is limited due to rapid cellular degradation.
Thus, inhibiting 2-AG hydrolyzing enzymes, such as MGL, is
considered a promising pharmacological approach to modulate EC
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raised 2-AG levels and induced cannabinoid receptor-dependent
effects like analgesia, hypomotility, and hypothermia [9]. These
observations indicate that MGL degrades 2-AG and hence plays an
important role in EC signaling.
A search in the yeast genome database unveiled the gene YJU3
(YKL094W) to encode a putative monoacylglycerol lipase, based on
23% sequence identity to mouse and human MGL, suggesting a high
level of conservation of enzymes involved in EC metabolism [10].
Yju3p was previously identiﬁed by mass spectrometry as a lipid
droplet protein, consistent with a role in lipid metabolism [10]. The
enzymology of TAG catabolism in yeast has recently been character-
ized in greater detail [11–13], and it shows a high level of functional
conservation to mammalian cells. Whereas Tgl4p functions as a TAG
lipase, Tgl3p has both TAG and DAG lipase activities [13], in analogy to
the catalytic cascade governed by adipose triglyceride lipase, ATGL,
and hormone sensitive lipase, HSL [14]. However, no speciﬁc MGL has
been described yet in yeast. Furthermore, alternative pathways for
MAG metabolization, i.e., for the resynthesis of diacylglycerol, are
uncharacterized in that organism.
Here we provide experimental evidence that Yju3p indeed
functions as the major monoacylglycerol lipase in yeast. In addition,
our data indicate that acyltransferases such as Dga1p and Lro1p play a
role in MAG metabolism.
2. Material and methods
2.1. Strains and media
The yeast strains used in this study were BY4742 (MATa his3Δ1
leu2Δ0 lys2Δ0 ura3Δ0), yju3Δ (MATa his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
YKL094W∷kanMX4), dga1Δ (MATa his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0
YOR245C∷kanMX4), the dga1Δ lro1Δ double-mutant strain (MATa
his3Δ1 leu2Δ0 lys2Δ0 ura3Δ0 YOR245C∷kanMX4 YNR008W∷kanMX4),
and the dga1Δ lro1Δ yju3Δ triple-mutant strain (MATa his3Δ1 leu2Δ0
ura3Δ0 YOR245C∷kanMX4 YNR008W∷kanMX4 YKL094W∷kanMX4).
Wild-type and single mutant strains were obtained from Euroscarf
(Frankfurt, Germany), the double- and triple-mutant strains were
generated by standard genetic crosses and tetrad dissection and were
veriﬁed by colony PCR using gene deletion speciﬁc primers. The
Escherichia coli strain TOP10F′ ([proAB, laqIq, lacZΔM15, Tn10(Tetr)],
mcrAΔ(mrr-hsdRSM-mcrBC), phi80ΔlacZM15, ΔlacX74, deoR, recA1, ara-
D139Δ(ara, leu), 7697galU, galK, D-rps(streptomycinr), endA1, nupG) was
used for plasmid ampliﬁcation and puriﬁcation. Yeast cells were grown in
YPDmediumcontaining1%yeast extract, 2%peptone, and2%glucoseor in
YNB minimal medium containing 0.67% yeast nitrogen base, 2% glucose,
and the respective amino acids and bases. Yeast transformants carrying
expression plasmids were selected in uracil-free medium. Geneticin
resistance was scored on YPD plates containing 200 mg/l geneticin
(G418; Calbiochem, Merck, Whitehouse Station, USA). Sporulation
medium contained 0.25% yeast extract, 0.1% glucose, and 1% potassium
acetate. Ampicillin-resistant E. coli transformants were selected on LBA
plates containing 0.5% yeast extract, 1% peptone, 0.5% NaCl, and 100mg/l
ampicillin (Roche, Basel, Switzerland). Yeast strainswere grownat30 °C
on a rotary shaker with vigorous aeration. Cell growth was monitored
with a Casy®TTC cell counter (Schärfe System, Reutlingen,Germany) or
by measuring the optical density at 600 nm (OD).
2.2. Construction of a plasmid encoding pGFP–MGL
A pcDNA4/Hismax C vector (Invitrogen, Carlsbad, CA) containing
the murine MGL open reading frame was digested with BamHI and
XhoI, and the MGL open reading frame was inserted into the BamHI/
XhoI restriction sites of plasmid pUG36 (kindly provided by H.
Hegemann, University of Duesseldorf, Germany) for the expression
and subcellular localization of the fusion protein GFP–MGL in yeast.Plasmids were transformed into yeast using the lithium acetate
method [15], and colonies were selected on plates lacking uracil.
2.3. Cloning, overexpression and puriﬁcation of His-tagged Yju3p
For the overexpression of Yju3p in E. coli, the gene was excised
from the yeast vector pYEX-4 T-1 using the restriction enzymes
BamHI and EcoRI and ligated into the pET21a vector (Novagen, Merck,
Whitehouse Station, USA), using standard protocols. To generate an
N-terminal His-tag, the gene was again cleaved from pET21a using
BamHI and XhoI and cloned into the vector pPROEX HTb (Invitrogen,
Carlsbad, CA, USA), which provides the coding sequence for an N-
terminal (His)6 tag. The clone pProExHtb-YJU3 was transformed into
E. coli BL21 (DE3) and gene expressionwas induced inmidlog phase at
37 °C for 4 hours using 0.5 mM IPTG. The harvested cells were lysed by
sonication in a buffer containing 50 mM Tris–HCl (pH 8.0), 100 mM
NaCl, and 0.5% NP-40. After centrifugation (27,000×g at 4 °C, 30 min),
the soluble fraction was loaded on to a HisTrap™ FF column
(Pharmacia, GE Healthcare) and eluted using buffer containing
50 mM Tris (pH 8.0), 100 mM NaCl, 10% glycerol, and 240 mM
imidazole. The protein sample was dialysed against a buffer contain-
ing 50 mM Tris (pH 8.0) 100 mM NaCl, 20% glycerol, 1 mM DTT, and
concentrated in the presence of 8 mM Mega8.
2.4. Cell fractionation and isolation of lipid droplets
Yeast cells were harvested in the early stationary phase, washed in
deionized water, and resuspended in 0.25 M sucrose with 1 mM EDTA
containing 2 mg/l antipain, 1 mg/l pepstatin, 20 mg/l leupeptine as
protease inhibitors. Cells were broken with glass beads in a
Merckenschlager homogenizer (Braun Biotech International GmbH,
Melsungen, Germany) under CO2 cooling. Cell debris was removed by
centrifuging at 1000×g for 10 min. The supernatant was transferred
to centrifugation tubes, overlaid with 50 mM potassium phosphate
buffer pH 7.5 containing 100 mM KCl and 1 mM EDTA ( buffer A), and
centrifuged at 100,000×g for 1 h to collect the ﬂoating lipid layer,
cytosolic fraction, and crude membrane fraction. Lipid droplet (LD)
and membrane fractions were puriﬁed by a subsequent step of
centrifuging at 100,000×g. For protein determination, aliquots of the
cell fractions were mixed with a 4-fold volume of acetone and
incubated overnight at −20 °C to precipitate proteins and to remove
lipids. After centrifuging at 10,000×g for 30 min, precipitated protein
was dissolved in 0.1% SDS and 0.3 M NaOH and protein concentration
was determined with a BCA protein assay according to the manufac-
turer's instructions (BCA™ Protein Assay Kit, Pierce, Illinois, USA),
using BSA as a standard.
2.5. Triacylglycerol hydrolysis activity of isolated LD fractions
Triacylglycerol hydrolysis activity of isolated LDs was determined
by using 25–50 μg of LD protein in a total volume of 100 μl of buffer A
and incubation with 100 μl of [carboxyl-14C] trioleoylglycerol (ﬁnal
concentration of 300 μmol/l and a speciﬁc activity of 15 μCi/ml) for
1 h at 37 °C in a shaking water bath. The substrate was prepared as
follows: trioleoylglycerol was dried under a stream of nitrogen,
emulsiﬁed by sonication with 45 μmol/l phosphatidylcholine/phos-
phatidylinositol (PC/PI, 3:1) in 100 mM potassium phosphate buffer
pH 7.5, and adjusted to 5% defatted BSA. The reaction was stopped by
the addition of 1 ml of chloroform/methanol (2:1, vol./vol.) contain-
ing 1% acetic acid and lipids were extracted by vortexing. After
centrifuging at 1000×g for 10 min, the lower phase was collected,
dried under a stream of nitrogen, and applied onto silica gel plates
(silica gel 60, Merck, Whitehouse Station, USA). Lipids were separated
using chloroform/acetone/acetic acid (92:6:1, vol./vol./vol.) as the
solvent system, and radioactivity was detected after exposure to
radiosensitive screens by scanning with a Storm™ 860 scanner (GE
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scraped off the plates, and radioactivity was measured by liquid
scintillation counting.
2.6. Monoacylglycerol hydrolase activity assay
Monoacylglycerol hydrolase (MGH) activity was assayed with
either puriﬁed recombinant Yju3p or cell homogenates. Puriﬁed
Yju3p was dialyzed against a buffer containing 50 mM Tris (pH 7.4)
and 100 mM NaCl before measurements to remove glycerol. Samples
were incubated with 100 μl of substrate containing either 1 mM rac-1
(3)-oleoylglycerol (rac-1(3)-OG) or 2-oleoylglycerol (2-OG; Sigma
Aldrich, St. Louis, USA), complexed to defatted BSA at a molar ratio ofFig. 1. Sequence alignment and structural comparison of humanMGL (hMGL), mouse MGL (m
sequence from Yju3p using Clustal W2 [45]. Identical and highly similar residues are indica
turn-like residues as used in Bork et al. [46]. h, hydrophobic; a, aromatic; 1, aliphatic; 0, S/T;
motif and residues of the catalytic triad which are located on loop regions are highlighted i
strands: arrows) and residues within the cap-region (highlighted in italics) were assigned1:1 in 100 mM potassium phosphate buffer (pH 6–7.5), sodium
acetate buffer (pH 4–5.5), or Tris–HCl buffer (pH 8–9). Reactions were
carried out at 37 °C for 20 min, which is in the linear range of the
reaction, and stopped by the addition of 100 μl of chloroform. Samples
were centrifuged at 10,000×g for 10 min, and aliquots of the upper
phase were collected to determine the free glycerol concentration
using a commercial kit (Sigma Aldrich, St. Louis, USA).
2.7. Monoacylglycerol acyltransferase activity assay
To determine MGAT activity, 50 μg of protein in a ﬁnal volume of
10 μl were preincubated for 3 min at 25 °C with 170 μl of substrate
containing 50 μmol/l 2-oleoylglycerol, 100 μmol/l PC/PI (3:1,MGL), and Yju3p. The sequences of MGL from human andmouse were aligned with the
ted with (*) or (:), respectively. A consensus sequence (cons.) was generated without
p, polar; c, charged; +, positive;−, negative; s, small; u, tiny. The conserved G-X-S-X-G
n white and grey boxes, respectively. Secondary structure elements (helices: cylinders,
as observed in the crystal structure of hMGL [35].
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buffer (pH 7.0). The reaction was started by the addition of 20 μl 14C-
labeled oleoyl-coenzyme A (ﬁnal concentration 20 μmol/l with a
speciﬁc activity of 55 μCi/μmol), and was stopped after 10 min at
25 °C by the addition of 1 ml of chloroform/methanol (2:1, vol./vol.)
and vortexing. After centrifuging at 1000×g for 10 min, the lower phase
was collected, evaporated under a streamof nitrogen, and redissolved in
chloroform. Lipid extracts were applied onto silica gel plates and
separated using hexane/diethylether/acetic acid (70:30:1, vol./vol./
vol.) as the solvent system. DAG and TAG spots were scraped off the
plates, and radioactivitywasdeterminedby liquid scintillation counting.2.8. Microscopy
yju3Δ cells harboring the plasmid pMGL-GFP were cultivated for
24 h in YNB medium without uracil. Microscopy was performed on a
Leica SP2 confocal microscope using a 100× oil immersion objective
(NA 1.4). GFP was excited at 488 nm, ﬂuorescence emission was
detected between 500 and 535 nm. Nile Red staining of yeast lipid
droplets was performed according to Wolinski and Kohlwein [16],
which allows for optimized color separation. Nile Red was excited at
543 nm, and ﬂuorescence emission was detected between 550 and
575 nm. Transmission images were recorded using differential
interference contrast (DIC) optics.Fig. 2. Enzymatic properties of Yju3p. (A) MGH activity of wild-type and yju3Δ cell lysates
dependence of MGH activities in wild-type (closed squares) and yju3Δ (open squares) cel
systems were used: 75 mM sodium acetate buffer for pH 4 to 5.5; 75 mM potassium phospha
of His-tagged recombinant Yju3p. His-tagged Yju3p was expressed in E. coli, and the protein w
of SDS–PAGE. Lane 1: Molecular weight protein standard. Lane 2: Yju3p after puriﬁcation. R
(3)-OG and 2-OG as substrates at pH 7.5. (D) Saturation curve of Yju3p activity and Lineweav
at pH 7.5. All experiments were performed in triplicates and are representative of at least t2.9. Lipid analysis
For analysis of neutral lipids, cells were brokenwith glass beads by
vigorous shaking, and lipids were extracted with chloroform/
methanol 2:1 (vol./vol.) as described [17]. Aliquots of the lipid
extracts were applied onto silica gel plates and separated with
chloroform/acetone/acetic acid (90:8:1, vol./vol./vol.) as the solvent
system. Lipids were visualized by carbonization after spraying the
plates with 10% CuSO4 (wt./vol.) and 10% H3PO4 (vol./vol.) and
heating them to 120 °C for 30 min.2.10. Metabolic labelling
Stationary phase cultures were inoculated into fresh medium at a
density of 2×610 cells/ml and grown for 10 h to the log phase. For in
vivo labelling, cells equivalent to 25 OD were harvested, resuspended
in 5 ml of medium containing 1 μCi/ml 14C-palmitic acid (60 mCi/
mmol), and incubated for 1 h at 30 °C. Labeled cells were harvested by
centrifugation, washed 1×with 0.1% SDS and 3× with deionized
water, and frozen in liquid nitrogen. Cells were broken with glass
beads by vigorous shaking, and lipids were extracted with chloro-
form/methanol 2:1 (vol./vol.). Aliquots of the lipid extracts were
applied onto silica gel plates and separated with chloroform/acetone/
acetic acid (90:8:1, vol./vol./vol.) as the solvent system. Radioactivity. Samples were incubated with rac-1(3)-OG and 2-OG as substrates at pH 7.5. (B) pH
l lysates. Samples were incubated with rac-1(3)-OG as substrate. The following buffer
te buffer for pH 6 to 7.5; 75 mM Tris–HCl buffer for pH 8 to 9. (C) Left panel: Puriﬁcation
as puriﬁed by afﬁnity chromatography. Purity of the protein was determined bymeans
ight panel: Stereospeciﬁcity of puriﬁed Yju3p. Puriﬁed Yju3p was incubated with rac-1
er-Burk plot (insert). The puriﬁed enzymewas incubated with rac-1(3)-OG as substrate
wo independent experiments. Data are presented as mean±SD. ***pb0.001.
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with a Storm™ 860 scanner (GE Healthcare, Piscataway, NJ). For
quantiﬁcation, lipid fractions were scraped off the plates according to
comigrating standards, and radioactivity was measured by liquid
scintillation counting.
2.11. Statistical analysis
Statistical signiﬁcance was determined by the Student's unpaired t
test (two-tailed). Group differences are considered signiﬁcant for
pb0.05 (*), pb0.01 (**), and pb0.001 (***).
3. Results
3.1. Identiﬁcation of Yju3p as a monoacylglycerol lipase
A database search unveiled that yeast Yju3p (encoded by gene
YKL094W) possesses more than 20% sequence identity to mammalian
MAG lipases [18]. Yju3p consists of 313 amino acids and was predicted
to be a serine hydrolase harboring a G-X-S-X-G motif and an α/β
hydrolase fold, which are both characteristics for lipolytic enzymes [19].
Based on BLAST sequence homology analysis [20,21], the catalytic triad
of Yju3p can be assigned to Ser123, Asp251, and His281 (Fig. 1).
To provide experimental evidence for the biological function of
Yju3p as a MAG lipase, we tested cell extracts of the yju3Δmutant and
the wild-type strain for their activity in vitro. As shown in Fig. 2A, the
mutant strain yju3Δ lacksdetectableMGL activity at pH7.5 against rac-1
(3)-OG, andhydrolysis of 2-OGwas reducedby∼90% compared towild-
type. This demonstrates that Yju3p indeed functions as a MAG lipase in
yeast. To investigate whether other lipases exist which are active at
lower or higher pH, we performed MGH assays at different pH values.Fig. 3.MGH activities in subcellular fractions and localization of heterologous expressedmuri
a yju3Δ strain harbouring the empty plasmid were fractionated into cytosol, membranes, an
relative to the MGH activity of wild-type cell lysate. Measurements were performed in trip
mean±SD; n. det. indicates that samples contained no detectable activity. (B) A MGL–GFP
scanning microscopy. Nile red staining of LDs was used to visualize the colocalization of thWild-type cell lysates exhibitedMGH activity over a broad pH spectrum
(pH 4.5 to 8). In contrast, MGH activity was barely detectable in mutant
lysates (Fig. 2B) demonstrating that Yju3p indeed represents the major
monoacylglycerol lipase in yeast. To conﬁrm Yju3p function, a His-
tagged Yju3p fusion protein was expressed in E. coli and puriﬁed using
afﬁnity chromatography. The puriﬁed fusion protein with a molecular
mass of 39 kDa hydrolyzed rac-1(3)-OG and 2-OG at similar rates
(Fig. 2C). Saturation analysis of Yju3p activity revealed a Vmax of
10.3 mmol/h⋅mg (170 U/mg; Fig. 2D). The apparent Km of the enzyme
was determined to be 260 μMwhich is close to the values reported for
mouse and ratMGL (300 μMand 200 μM, respectively) [22]. No activity
was observed using oleoyl-ethanolamine (OEA), diolein, or triolein as
substrate (not shown). Together, these observations demonstrate that
Yju3p speciﬁcally hydrolyzes MAG, and with a remarkably high speciﬁc
activity.
3.2. Subcellular distribution of Yju3p activity and heterologous
expression of murine MGL in yeast
Yju3p was previously detected on puriﬁed lipid droplets (LD) by
mass spectrometric analysis [10] and was found by ﬂuorescence
microscopy of a GFP fusion protein to localize both to LD and to the
endoplasmic reticulum [23]. To investigate the cellular distribution of
MGH activity, cells were fractionated into cytosol, membranes, and
lipid droplets for activity assays. As shown in Fig. 3A, MGH activity
was not detectable in the cytosolic fraction. Compared to whole cell
lysates, the speciﬁc activity in membranes and lipid droplets was
enriched 3- and 10-fold, respectively, consistent with the subcellular
distribution of the protein as determined by GFP ﬂuorescence
microscopy [23]. Subcellular fractions of Yju3p-deﬁcient cells exhibited
almost no detectable activity.neMGL. (A) A yju3Δ strain overexpressing murineMGL as well as a wild-type strain and
d lipid droplets, and MGH activities were determined. Speciﬁc activities are expressed
licates and are representative of two independent experiments. Data are presented as
fusion protein was overexpressed in yju3Δ, and localization was determined by laser
e MGL–GFP fusion protein with LDs.
Fig. 4. Yju3p deﬁciency causes MAG accumulation in vitro and can be complemented by
the expression of murine MGL. Isolated LDs were incubated with radiolabeled
trioleoylglycerol as substrate. Lipolytic products were extracted, separated by TLC. For
quantiﬁcation, FFA, DAG, and MAG comigrating with lipid standards was scraped off, and
the radioactivity of samples was determined by liquid scintillation counting.
(A) Generation of lipolytic products by LD preparations of wild-type and yju3Δ cells.
(B) Left panel: TLC autoradiogram of MAG bands showing the signals obtained for wild-
type and yju3Δ samples expressing GFP, and for yju3Δ samples expressing a GFP–MGL
fusion protein. Right panel: Quantitation of MAG signals by liquid scintillation counting.
(C) Generation of lypolytic products by LD preparations ofwild-type and yju3Δ cells in the
presence of pancreatic lipase. Measurements were performed in triplicates and are
representative for at least two independent experiments.Data arepresentedasmean±SD.
**pb0.01; ***pb0.001; n. det., not detectable.
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the yju3Δ strain and determined its activity in subcellular fractions
(Fig. 3A). Interestingly, MGH activity was detectable only in whole cell
lysates and the LD fraction but was completely absent from the cytosol
andmembranes. The almost exclusive localization of the heterologous
enzyme to LD in the yju3Δ cells was conﬁrmed by ﬂuorescence
microscopy using GFP-tagged MGL (Fig. 3B).
3.3. Yju3p deﬁciency causes MAG accumulation in vitro and can be
complemented by the expression of murine MGL
To investigate the role of Yju3p speciﬁcally in TAG hydrolysis, we
incubated isolated LDs with radiolabeled TAG and separated the
reaction products by TLC. Quantiﬁcation of the reaction products by
liquid scintillation counting revealed that FFA release in Yju3p-
deﬁcient LD preparations was decreased by 40%. DAG accumulated to
equal levels in both strains and MAG levels were increased 10-fold in
the absence of Yju3p (Fig. 4A). Overexpression of murine MGL in the
yju3Δ strain prevented the accumulation of MAG in Yju3p-deﬁcient
preparations (Fig. 4B) demonstrating that Yju3p is the functional
orthologue of murine MGL. To increase the formation of MAG, we
added pancreatic lipase to yeast LD fractions. This mammalian lipase
exhibits very low MGH activity in comparison to its capability of
hydrolyzing TAG and DAG [24]. Addition of pancreatic lipase to wild-
type LDs stimulated the lipolytic activity ∼30-fold and led to almost
complete degradation of TAG into glycerol and FFA. In contrast,
pancreatic lipase caused a massive accumulation of MAG in Yju3p-
deﬁcient preparations (Fig. 4C).
3.4. Dga1p exhibits DGAT and MGAT activity
In mammals, the acyl-CoA dependent re-esteriﬁcation of MAG to
DAG represents an important step in lipid metabolism. So far, acyl-
CoA:monoacylglycerol acyltransferase (MGAT) activity has not been
described for yeast, which could counteract MAG accumulation in
Yju3p-deﬁcient cells (see below). Since mammalian monoacylgly-
cerol acyltransferase 3 (MGAT3) also displays DGAT activity [25], we
hypothesized that the orthologous yeast DGAT enzyme, Dga1p, might
possess dual MGAT and DGAT activity. Dga1p is an LD-associated
protein and, together with Lro1p, is essential for efﬁcient TAG
synthesis in yeast [26]. Indeed, MGAT activity was decreased by 60%
in Dga1p-deﬁcient preparations, compared to the wild-type control
(1.93±0.30 and 0.77±0.13 nmol/h⋅mg protein respectively,
pb0.01), indicating that Dga1p also catalyzes the esteriﬁcation of
MAG.
3.5. Catabolic and anabolic reactions affect MAG levels in vivo
Our observations suggested that Yju3p complements the action of
upstream lipases Tgl4p and Tgl3p in TAG and DAG hydrolysis andmay
also hydrolyze MAG derived from the degradation of phospholipids.
To test whether Yju3p deﬁciency results in the accumulation of MAG
in vivo, total lipids from wild-type and the yju3Δ mutant strain were
extracted and analyzed by TLC. Yeast cells preferentially mobilize
their TAG stores after transfer from a stationary culture into fresh
glucose-containing medium [13]. Therefore, we focused our analysis
on cells from lag-phase and early log-phase of growth (0–4 h of
cultivation). As shown in Fig. 5A, DAG and FFAwere readily detectable
in both wild-type and mutant cells. In contrast, MAG were neither
detectable in wild-type lipid extracts nor in extracts of Yju3p-
deﬁcient cells. To switch to a more sensitive detection system, cells
were metabolically labelled with 14C-palmitic acid. Subsequently,
lipids were extracted, subjected to TLC analysis, and exposed to a
radiosensitive screen. Under these conditions, we were able to detect
signals comigrating with MAG standards (Fig. 5B). Compared to the
wild-type control, MAG levels were increased 5-fold in Yju3-deﬁcientcells, which decreased to wild-type levels upon heterologous
expression of murine MGL.
To test whether anabolic reactions affect MAG levels, we tested
mutant cells lacking the acyltransferases Lro1p and Dga1p. Lro1p
catalyzes the acyl transfer from phospholipids to DAG and was also
shown to accept MAG as an acyl acceptor [27]. In the absence of both
enzymes, TAG synthesis in yeast is virtually abolished [28]. Compared
to wild-type cells, no signiﬁcant changes in MAG levels were detected
in dga1Δ lro1Δ double mutants. However, in the dga1Δ lro1Δ yju3Δ
triple mutant, cellular MAG levels were increased by 60% compared to
yju3Δ cells (Fig. 5C). This suggests that in the absence of Yju3p, MAG
generated by the degradation of TAG or phospholipids are re-
esteriﬁed to DAG and, subsequently, used for TAG or phospholipid
synthesis.
Fig. 5. The effect of Yju3p deﬁciency on MAG levels in vivo. (A) Lipid analysis of wild-type and yju3Δ. Cells were harvested in different growth phases as indicated by the time points
(0 h, stationary phase; 1 h and 3 h, lag phase; 5 h early log phase). Lipids were separated by TLC and visualized by charring at 120 °C. Lipids were identiﬁed by comigration with lipid
standards. SE, steryl ester; ERG, ergosterol. (B) Detection of MAG in yju3Δ. Cells were labeled with 14C-palmitic acid, lipids were separated by TLC, and radioactivity was visualized by
exposure to a radiosensitive screen. MAG was identiﬁed with comigrating lipid standards and the associated activity was quantiﬁed by liquid scintillation counting. Left panel: TLC
autoradiogram showing MAG-associated signals of wild-type and yju3Δ expressing GFP, and of yju3Δ expressing a GFP-MGL fusion protein. Right panel: Quantitation of MAG signals
by liquid scintillation counting. (C) MAG-associated activity of wild-type, yju3Δ, dga1Δ lro1Δ, and dga1Δ lro1Δ yju3Δ. Measurements were performed in triplicates and are
representative for two independent experiments. Data are presented as mean±SD. *pb0.05; ***pb0.001.
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In this study, we identiﬁed Yju3p as the major yeast monoacylgly-
cerol lipase sharing structural and functional homology with
mammalian MGL. MGH activity of Yju3p was readily detectable in
yeast lysates or in puriﬁed preparations of the enzyme. Deletion of the
YJU3 gene abolished MGH activity in vitro using rac-1(3)-MAG as thesubstrate, whereas residual activity against 2-MAG remained detect-
able in the mutant. This observation suggests that at least one
additional enzyme exists in yeast which preferentially hydrolyses
MAG esteriﬁed at the sn-2 position.
Earlier studies identiﬁed Yju3p as a lipid droplet and membrane
bound protein [10,23]. In accordance with these studies, we found
Yju3p activity exclusively in isolated lipid droplet and membrane
Fig. 6. Hypothetical pathways of MAGmetabolism. MAG is generated by the catabolism
of phospholipids and TAG and can be further metabolized by several reactions. Yju3p
catalyzes the hydrolysis of MAG to glycerol and FFA. In addition, MAG can be esteriﬁed
to DAG in an acyl CoA-dependent manner by Dga1p. Furthermore, Lro1p, Are1p, and
Are2p, which are known to be involved in neutral lipid synthesis, might contribute to
the esteriﬁcation of MAG. Finally, lipid kinases such as Dgk1p could mediate the
phosphorylation of MAG to lysophosphatidic acid (LPA).
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MGH activity. Interestingly, mouse GFP-MGL almost exclusively
localized to LDs when expressed in yeast. To our knowledge, MGL
was shown to bind to membrane structures and was never identiﬁed
as LD-associated protein in mammalian cells so far. The presence of
MGH activity on LDs suggests that TAG can be completely hydrolyzed
into glycerol and FFA on the lipid droplet surface. In yeast, degradation
of TAG is mainly catalyzed by the lipases Tgl3p and Tgl4p [13,29]. The
lack of both enzymes causes a severe lipolytic defect and accumula-
tion of TAG. Tgl3p was also reported to hydrolyze DAG [13]
implicating that this enzyme is responsible for the generation of
MAG. In mammalian cells, three enzymes are responsible for efﬁcient
TAG breakdown, namely ATGL, HSL, and MGL. Lack of ATGL and HSL
activity in mice results in accumulation of TAG and DAG, respectively,
in adipose tissue and in other tissues [30,31]. Currently, a mouse
model lacking MGL does not exist. However, in vitro experiments and
in vivo studies using a speciﬁc inhibitor for the enzyme demonstrate
that MGL is required for efﬁcient MAG hydrolysis [9,32,33].
Very recently, the three-dimensional structure of humanMGL was
determined [34,35] and revealed an α/β-hydrolase fold, as predicted.
As observed in many members of the α/β-hydrolase fold family, the
catalytic triad is covered by a cap (ranging from residues 151 to 225 in
human MGL). The channel in proximity of the catalytic site allows
accommodation of long lipid chains andwidens towards the surface of
the protein. In the case of human MGL, the cap region is of wide U-
shaped architecture which is attributed to allow access to the catalytic
site for a broad range of substrates. Notably, a surface-exposed
hydrophobic region was identiﬁed in this lid region and is speculated
to either facilitate localization on the membrane to get in contact with
its lipophilic substrates. Although the corresponding residues are not
highly conserved in Yju3p, the hydrophobic nature of this protein
domain (Q165-V178) is well preserved.
Remarkably, MGH-speciﬁc activitiesmeasured in yeast preparations
were more than 1000-fold higher compared to enzyme activities
reported for the TAG lipases [11,13]. Moreover, LD-associated Yju3p
efﬁciently prevented MAG accumulation in vitro when lipolysis was
stimulated∼30-fold by the addition of pancreatic lipase. This implies an
overrepresentation of MGH activity on LDs. Mammalian MGL is also
known to possess very high speciﬁc activity compared to other
acylglycerol hydrolases. The reason for these high MGH activities in
both mammalian cells and in yeast remains elusive. Presumably, MAGs
are rapidlymetabolized as soon as these lipid intermediates are formed.
Reis et al. [36] suggested that 2-MAG can inhibit lipolysis by displacing
lipases from the lipid–water interface due to an interfacial competition.
However, we did not observe TAG accumulation or a substantial
reduction in LD-associated lipolytic activity in Yju3p-deﬁcient cells.
MAGs were also shown to possess antimicrobial activity [37] and
saturated monoacylglycerols are highly toxic when fed to mice [38].
Thus, it is reasonable to assumethat highMGHactivities are necessary to
protect cells from toxic concentrations of MAG.
Interestingly, the lack of MGH activity was only associated with
minor MAG accumulation in yju3Δ cells. We therefore considered the
possibility that MAG may be secreted into the culture media, but this
was not the case (data not shown). These observations suggest that
alternative mechanisms exist for metabolizing MAG. In mammals, the
acyl-CoA dependent esteriﬁcation of MAG by MGATs is known to play
an important role in lipid metabolism and energy homeostasis, but no
such activity was reported for yeast before. Our data show that MGAT
activity is clearly present in yeast and that Dga1p, the homologue of
mammalian DGAT2 [26,39], mediates ∼60% of this activity in yeast.
Are1p and Are2p might be responsible for the residual acyl-CoA-
dependent acyltransferase activity [40]. It remains to be shown,
however, whether these enzymes also accept MAG as a substrate.
Lro1p, which catalyzes the transfer of an acyl group from phospho-
lipids to diacylglycerol [28], might also play a role inMAGmetabolism.
In triple-mutant cells, lacking Yju3p, Dga1p, and Lro1p, MAG levelswere increased compared to Yju3p-deﬁcient cells, indeed suggesting
that acyltransferase or transacylase reactions contribute to MAG
metabolism in vivo. In addition, the diacylglycerol kinase Dgk1p [41],
could potentially utilize MAG for the synthesis of lysophosphatidic
acid, which is subsequently further acylated to phosphatidic acid and
channeled into phospholipid or TAG metabolism. Thus, additional
metabolic pathways exist, such as transacylation or phosphorylation,
which allow an efﬁcient metabolization of MAG (Fig. 6).
MGL was recognized in recent years as a potential player in EC
metabolism [42]. 2-AG and anandamide (N-arachidonoylethanola-
mide; AEA) are considered as the main endogenous agonists of
cannabinoid receptors [7]. Currently, it is not known whether MAG or
N-acylethanolamines also possess a signaling function in yeast.
Notably, several yeast proteins display homology to mammalian
enzymes involved in the synthesis or in the degradation of 2-AG and
AEA [43]. Yeast also expresses a phospholipase D encoded by the gene
YPL103C, which cleaves N-acylphosphatidylethanolamine (NAPE)
[44], the precursor of N-acylethanolamines. Thus, studying molecular
mechanisms that control MAG and N-acylethanolamine metabolism
in yeast might unveil new strategies for therapeutic interventions
modulating the endocannabinoid system.
In summary, we have identiﬁed Yju3p as the functional orthologue
of mammalian monoglyceride lipase in yeast. However, Yju3p-
deﬁcient cells accumulated MAG only at low concentrations impli-
cating that other cellular activities exist, such as acyltransferase or
phosphorylation reactions, which contribute to the metabolization of
MAG. As Yju3p localizes to LDs and cellular membranes, we propose
that it is required for efﬁcient hydrolysis of MAG generated from the
catabolism of TAG and glycerophospholipids. The absence of a
scorable phenotype for the Yju3p-deﬁcient mutant under multiple
conditions is puzzling given its 1000-fold higher speciﬁc activity
compared to other lipid hydrolases, such as Tgl3p or Tgl4p, and
requires further investigation.
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